The emergence of omics technologies over recent years has revolutionized the model of healthcare delivery and disease prevention. Omics uses tools that allow us to study our genetic makeup to assess the human condition in both wellness and illness and enables PRECISION testing, leading to PREDICTION of disease, that drives PREVENTION.

Implementation of these tools and techniques requires investment in state-of-the-art technology and an experienced and dynamic team of specialists who can bridge genomic technologies and medical practice.

Genalive is empowered by one of the world’s leading life science organizations, BGI Group, providing many of the technologies, tools and methods that support Genalive’s extensive offering of genetic, routine pathology, and specialized testing services.

With our BGI partners, Genalive is committed to enabling and accelerating scientific innovation, strengthening the prevention and control of genetic diseases, and empowering health professionals with advanced diagnostic tools. Utilizing cutting-edge sequencing and powerful bioinformatics tools, we can provide our customers with affordable genetics testing and support them in making informed decisions about their health, improving the lives of people in the community.